Childhood abuse and treatment response in patients with irritable bowel syndrome: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 1, 2009, Pages 79-88

  Han, C ^a,b   Masand, P S ^a   Krulewicz, S ^c   Peindl, K ^a   Mannelli, P ^a   Varia, I M ^a   Pae, C U ^a,d   Patkar, A A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Korea University Ansan Hospital   (South Korea)

^c GLAXOSMITHKLINE   (United States)

^d The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Irritable bowel syndrome; Paroxetine controlled release; Selective serotonin reuptake inhibitors; Sexual abuse; Treatment response

Indexed keywords

PAROXETINE;

ADULT; AGED; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CHILD ABUSE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; HUMAN; INTERACTIVE VOICE RESPONSE SYSTEM; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT COMPLIANCE; PERCEIVED STRESS SCALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL AND PHYSICAL ABUSE QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; CHILD; CHILD ABUSE; CHILD ABUSE, SEXUAL; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAROXETINE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58149308277     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00975.x     Document Type: Article

References (57)

1. Manning AP, Thompson WG, Heaton KW, Morris AF (1978) Towards positive diagnosis of the irritable bowel. British Medical Journal, 2, 653 654.
2. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS (2003) Comorbidity of irritable bowel syndrome in psychiatric patients: a review. American Journal of Therapeutics, 10, 61 67.
3. Mertz HR (2003) Irritable bowel syndrome. New England Journal of Medicine, 349, 2136 2146.
4. Drossman DA, Li Z, Andruzzi E et al. (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Digestive Diseases and Sciences, 38, 1569 1580.
5. Pikarinen U, Saisto T, Schei B, Swahnberg K, Halmesmaki E (2007) Experiences of physical and sexual abuse and their implications for current health. Obstetrics and Gynecology, 109, 1116 1122.
6. Longstreth GF, Wolde-Tsadik G (1993) Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Digestive Diseases and Sciences, 38, 1581 1589.
7. Reilly J, Baker GA, Rhodes J, Salmon P (1999) The association of sexual and physical abuse with somatization: characteristics of patients presenting with irritable bowel syndrome and non-epileptic attack disorder. Psychological Medicine, 29, 399 406.
8. Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC, Mitchell CM (1990) Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Annals of Internal Medicine, 113, 828 833.
9. Talley NJ, Fett SL, Zinsmeister AR (1995) Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. American Journal of Gastroenterology, 90, 366 371.
10. Delvaux M, Denis P, Allemand H (1997) Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. European Journal of Gastroenterology and Hepatology, 9, 345 352.
11. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. (1994) Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology, 107, 1040 1049.
12. Kooiman CG, Ouwehand AW, ter Kuile MM (2002) The Sexual and Physical Abuse Questionnaire (SPAQ). A screening instrument for adults to assess past and current experiences of abuse. Child Abuse and Neglect, 26, 939 953.
13. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D (2003) Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. American Journal of Physiology. Gastrointestinal and Liver Physiology, 284, G130 G137.
14. Masand PS, Gupta S, Schwartz TL et al. (2002) Paroxetine in patients with irritable bowel syndrome: a pilot open-label study. Primary Care Companion to the Journal of Clinical Psychiatry, 4, 12 16.
15. Kato O, Misawa H (2005) Treatment of diarrhea-predominant irritable bowel syndrome with paroxetine. Primary Care Companion to the Journal of Clinical Psychiatry, 7, 202.
16. Masand PS, Gupta S, Schwartz TL, Virk S, Hameed A, Kaplan DS (2005) Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study. Primary Care Companion to the Journal of Clinical Psychiatry, 7, 162 166.
17. Tabas G, Beaves M, Wang J, Friday P, Mardini H, Arnold G (2004) Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial. American Journal of Gastroenterology, 99, 914 920.
18. Creed F, Guthrie E, Ratcliffe J et al. (2005) Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? The Australian and New Zealand Journal of Psychiatry, 39, 807 815.
19. Tack J, Broekaert D, Fischler B, Oudenhove LV, Gevers AM, Janssens J (2006) A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut, 55, 1095 1103.
20. Kuiken SD, Tytgat GN, Boeckxstaens GE (2003) The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clinical Gastroenterology and Hepatology, 1, 219 228.
21. Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R (2005) The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Alimentary Pharmacology and Therapeutics, 22, 381 385.
22. Leserman J, Drossman DA, Li Z, Toomey TC, Nachman G, Glogau L (1996) Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosomatic Medicine, 58, 4 15.
23. Bass C, Bond A, Gill D, Sharpe M (1999) Frequent attenders without organic disease in a gastroenterology clinic. Patient characteristics and health care use. General Hospital Psychiatry, 21, 30 38.
24. Creed F, Fernandes L, Guthrie E et al. (2003) The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology, 124, 303 317.
25. Creed F, Guthrie E, Ratcliffe J et al. (2005) Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome. Psychosomatic Medicine, 67, 490 499.
26. Thompson W, Longstreth G, Drossman D (2000) Functional bowel disorders and functional abdominal pain. In : Drossman DACE, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II. The functional gastrointestinal disorders vol. 2, 2nd edn. McLean, VA : Degnon Associates, 351 432.
27. Drossman DA, Camilleri M, Mayer EA, Whitehead WE (2002) AGA technical review on irritable bowel syndrome. Gastroenterology, 123, 2108 2131.
28. Sheehan DV, Lecrubier Y, Sheehan KH et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 (Suppl 20 22 33 quiz 34-57.
29. Leserman J, Drossman DA, Li Z (1995) The reliability and validity of a sexual and physical abuse history questionnaire in female patients with gastrointestinal disorders. Behavioral Medicine, 21, 141 150.
30. Drossman DA, Li Z, Leserman J, Toomey TC, Hu YJ (1996) Health status by gastrointestinal diagnosis and abuse history. Gastroenterology, 110, 999 1007.
31. Kobak KA, Taylor LH, Dottl SL et al. (1997) A computer-administered telephone interview to identify mental disorders. JAMA, 278, 905 910.
32. Guy W (1976) ECDEU Assessment manual for psychopharmacology: Publication ADM 76-338. Rockville, MD, US : US Department of Health, Education and Welfare, 217 222.
33. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561 571.
34. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893 897.
35. Cole SR (1999) Assessment of differential item functioning in the Perceived Stress Scale-10. Journal of Epidemiology and Community Health, 53, 319 320.
36. Levine J, Schooler NR (1986) SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacology Bulletin, 22, 343 381.
37. Masand PS, Pae CU, Krulewicz S, Peindl K, Mannelli P, Varia IM, Patkar AA (2008) A double-blind, randomized, placebo-controlled trial of paroxetine controlled release in irritable bowel syndrome. Psychosomatics, in press.
38. Meltzer-Brody S, Leserman J, Zolnoun D, Steege J, Green E, Teich A (2007) Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstetrics and Gynecology, 109, 902 908.
39. Walker EA, Gelfand A, Katon WJ, Koss MP, Von Korff M, Bernstein D, Russo J (1999) Adult health status of women with histories of childhood abuse and neglect. American Journal of Medicine, 107, 332 339.
40. Talley NJ, Boyce PM, Jones M (1997) Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut, 41, 394 398.
41. Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC (2000) Effects of coping on health outcome among women with gastrointestinal disorders. Psychosomatic Medicine, 62, 309 317.
42. Scarinci IC, McDonald-Haile J, Bradley LA, Richter JE (1994) Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. American Journal of Medicine, 97, 108 118.
43. Arnow BA, Hart S, Scott C, Dea R, O'Connell L, Taylor CB (1999) Childhood sexual abuse, psychological distress, and medical use among women. Psychosomatic Medicine, 61, 762 770.
44. Stein JA, Golding JM, Diegel JM, Burnam MA, Sorensen SB (1988) Long-term psychological sequelae of child abuse: the Los Angeles epidemiologic catchment area study. In : Wyatt GE, Powell GJ, eds. Lasting effects of child sexual abuse, vol. 2. edn. Newbury Park : Sage, 135 154
45. Bagley C, Ramsay R (1985) Psychosocial correlates of suicidal behaviors in an urban population. Crisis, 6, 63 77.
46. Felitti VJ (1991) Long-term medical consequences of incest, rape, and molestation. Southern Medical Journal, 84, 328 331.
47. Briere J (1992) Medical symptoms, health risk, and history of childhood sexual abuse. Mayo Clinic Proceedings, 67, 603 604.
48. Springs FE, Friedrich WN (1992) Health risk behaviors and medical sequelae of childhood sexual abuse. Mayo Clinic Proceedings, 67, 527 532.
49. Fry R (1993) Adult physical illness and childhood sexual abuse. Journal of Psychosomatic Research, 37, 89 103.
50. Dinan TG, O'Keane V, O'Boyle C, Chua A, Keeling PW (1991) A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatrica Scandinavica, 84, 26 28.
51. Dancey CP, Taghavi M, Fox RJ (1998) The relationship between daily stress and symptoms of irritable bowel: a time-series approach. Journal of Psychosomatic Research, 44, 537 545.
52. Drossman DA (1997) Irritable bowel syndrome and sexual/physical abuse history. European Journal of Gastroenterology and Hepatology, 9, 327 330.
53. Drossman DA (1990) Personality and psychological factors in the irritable bowel syndrome. Gastroenterologie Clinique et Biologique, 14, 49C 53C.
54. Talley NJ, Boyce PM, Jones M (1998) Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut, 42, 47 53.
55. Atkinson JH, Slater MA, Wahlgren DR et al. (1999) Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain, 83, 137 145.
56. Talley NJ (2004) Antidepressants in IBS: are we deluding ourselves? American Journal of Gastroenterology, 99, 921 923.
57. Kirsch MA, Louie AK (2000) Paroxetine and irritable bowel syndrome. American Journal of Psychiatry, 157, 1523 1524.